Skip to main

Annual survey

We would appreciate it if you could complete our website survey, open until 28 November 2025.

Designation of Eltrombopag (Revolade) as an orphan drug - GlaxoSmithKline

This item is authorised by the following title:

Latest version
C2014G0122924 July 2014

Details

Title ID
C2014G01229
Registered
24 July 2014